Browse

Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted development.

Affected grafts may not unclasp from the delivery system. This may require conversion to open surgical repair and can result in patient death.

The latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be embracing a long-dismissed field of research.